×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
COYA – coya therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
COYA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/27
08:04 pm
coya
Wall Street Analysts Think Coya Therapeutics, Inc. (COYA) Could Surge 149.62%: Read This Before Placing a Bet [Yahoo! Finance]
Medium
Report
Wall Street Analysts Think Coya Therapeutics, Inc. (COYA) Could Surge 149.62%: Read This Before Placing a Bet [Yahoo! Finance]
3/27
08:15 am
coya
Coya Therapeutics, Inc. (NASDAQ: COYA) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $18.00 price target on the stock.
Medium
Report
Coya Therapeutics, Inc. (NASDAQ: COYA) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $18.00 price target on the stock.
3/26
08:15 am
coya
Coya Therapeutics Reports Progress from an Academic Supported First-in-Class Treg-derived Exosome Program
Neutral
Report
Coya Therapeutics Reports Progress from an Academic Supported First-in-Class Treg-derived Exosome Program
3/20
08:05 am
coya
Coya Therapeutics, Inc. (NASDAQ: COYA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $14.00 price target on the stock.
Medium
Report
Coya Therapeutics, Inc. (NASDAQ: COYA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $14.00 price target on the stock.
3/19
09:18 am
coya
Exosome Therapeutics Market Report 2025: 120+ Drug Candidates in Pipeline, Market to Reach $1.4 Billion by 2040, Growing at 41.1% CAGR [Yahoo! Finance]
Low
Report
Exosome Therapeutics Market Report 2025: 120+ Drug Candidates in Pipeline, Market to Reach $1.4 Billion by 2040, Growing at 41.1% CAGR [Yahoo! Finance]
3/18
09:44 am
coya
Coya Therapeutics, Inc. (NASDAQ: COYA) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $18.00 price target on the stock.
Medium
Report
Coya Therapeutics, Inc. (NASDAQ: COYA) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $18.00 price target on the stock.
3/18
08:15 am
coya
Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2024 Financial Results
Medium
Report
Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2024 Financial Results
3/10
08:58 am
coya
Coya Therapeutics, Inc. (NASDAQ: COYA) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $15.00 price target on the stock.
High
Report
Coya Therapeutics, Inc. (NASDAQ: COYA) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $15.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/18
08:26 am
coya
Form 10-K Coya Therapeutics, Inc. For: Dec 31
Medium
Report
Form 10-K Coya Therapeutics, Inc. For: Dec 31
3/18
08:20 am
coya
Form 8-K Coya Therapeutics, Inc. For: Mar 18
Medium
Report
Form 8-K Coya Therapeutics, Inc. For: Mar 18
2/25
09:30 pm
coya
Form 4 Coya Therapeutics, Inc. For: Feb 25 Filed by: GOLDSTEIN DOV A MD
Low
Report
Form 4 Coya Therapeutics, Inc. For: Feb 25 Filed by: GOLDSTEIN DOV A MD
2/25
09:30 pm
coya
Form 4 Coya Therapeutics, Inc. For: Feb 25 Filed by: ROSS WILBUR L JR
Low
Report
Form 4 Coya Therapeutics, Inc. For: Feb 25 Filed by: ROSS WILBUR L JR
2/25
09:30 pm
coya
Form 4 Coya Therapeutics, Inc. For: Feb 25 Filed by: Weinand Dieter
Low
Report
Form 4 Coya Therapeutics, Inc. For: Feb 25 Filed by: Weinand Dieter
2/25
09:30 pm
coya
Form 4 Coya Therapeutics, Inc. For: Feb 25 Filed by: Lee Ann
Low
Report
Form 4 Coya Therapeutics, Inc. For: Feb 25 Filed by: Lee Ann
2/25
09:30 pm
coya
Form 4 Coya Therapeutics, Inc. For: Feb 25 Filed by: Villalobos Anabella
Low
Report
Form 4 Coya Therapeutics, Inc. For: Feb 25 Filed by: Villalobos Anabella
2/14
04:27 pm
coya
Form SCHEDULE 13G/A Coya Therapeutics, Inc. Filed by: DME Capital Management, LP
Medium
Report
Form SCHEDULE 13G/A Coya Therapeutics, Inc. Filed by: DME Capital Management, LP
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: